Having a bit more of a look through the Dec qtr figures, there are a couple of interesting things.
There was no Commercial Ready Grant payment. This was probably delayed because of Christmas, but should have been close to $200k. So next quarter should have two payments ($350k to $420k in total).
Also PBO stated annual costs which fell in the period, including insurance. I don't know what their insurance cost is, but when HIH went under PBO said they would be up for government assistance in the range of $350k to $650k. So I guess that insurance bill is pretty big.
Don't forget that the new technologies are getting closer & closer. All funded by Panbio's profit. No capital raisings for this Biotech.
Mkt Cap $18m.
(I do hold)
PBO
panbio limited
